Australia markets closed

Healthy Extracts Inc. (HYEX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.00000.0000 (0.00%)
At close: 01:31PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.0000
Open2.0852
BidN/A x N/A
AskN/A x N/A
Day's range2.0000 - 2.0000
52-week range1.0300 - 7.2000
Volume2
Avg. volume513
Market cap5.928M
Beta (5Y monthly)1.67
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Healthy Extracts Launches First Anti-Aging Formulation, LONGEVITY

    LONGEVITY Anti-Aging™ BERGAMET’s New LONGEVITY Anti-Aging™ LAS VEGAS, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, has launched LONGEVITY Anti-Aging™, a new proprietary formulation designed to support skin vitality, arterial flexibility, and cellular and joint health. LONGE

  • GlobeNewswire

    Healthy Extracts Prepares for NYSE American Listing with Reverse Stock Split

    LAS VEGAS, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX, HYEXD), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, will effect a 1-for-120 reverse split of its common stock, effective at the opening of the market tomorrow, Friday, December 29, 2023. The reverse stock split will be implemented in connection with the company’s

  • GlobeNewswire

    Healthy Extracts Reports Third Quarter 2023 Results

    Net Revenue up 23%, with Strong Subscription-Based Revenue GrowthLAS VEGAS, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, reported results for the three and nine months ended September 30, 2023. All comparisons are to the year-ago period unless otherwise noted. Financial & O